Mallinckrodt Stock Forecast for 2023 - 2025 - 2030

Updated on 03/29/2024

Stock Rating
12
Price Target
$0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
12
Downside
-100.00%
Analysts
0
Price Target
$0.00

Mallinckrodt Stock Forecast and Price Target

In recent months, notable analysts have provided yearlong price targets for Mallinckrodt, with the average target coming in at $0.00. If it were to be achieved, this would result in a potential downside of approximately -,100 percent from the most recent closing price in October, 2023. The high end is $0.00, and the low is $0.00. If you want to invest in MNK stock, you might also want to take a look at how its competitors are doing.

$0.00

N/A

-

Mallinckrodt Fair Value Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
AMGN Stock Forecast Amgen Outperform 4
$275.36 Buy/Sell $303.65 14.40%
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$54.36 Buy/Sell $58.15 1.18%
ZTS Stock Forecast Zoetis Outperform 18
$183.49 Buy/Sell $220.47 20.72%
SUNPHARMA Stock Forecast Sun Pharmaceutical Industries Outperform 8
Rp1.59k Buy/Sell Rp1.52k -1.42%

Mallinckrodt Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Mallinckrodt's Revenue has seen a drop from $2.21B to $1.91B – a 13.51% decrease. For next year, analysts predict Revenue of $2.11B, which would mean an increase of 10.32%. Over the next eight years, experts predict that Mallinckrodt's Revenue will grow at a rate of 10.98%.

2023 Rev Forecast
$2.11B
2024 Rev Forecast
$2.16B
2025 Rev Forecast
$2.18B
2026 Rev Forecast
$2.09B
2027 Rev Forecast
$2.10B
2028 Rev Forecast
$2.12B
2029 Rev Forecast
$2.14B
2030 Rev Forecast
$2.12B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIIB Stock Forecast Biogen Outperform 10
$230.07 Buy/Sell $299.62 29.09%
BAYN Stock Forecast Bayer Hold 5
26.82€ Buy/Sell 45.15€ 26.77%
TEVA Stock Forecast Teva Pharmaceutical Industries Outperform 12
$13.35 Buy/Sell $11.59 19.85%

Mallinckrodt Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
VTRS Stock Forecast Viatris Inc Hold 8
$11.97 Buy/Sell $11.73 0.25%
JAZZ Stock Forecast Jazz Pharmaceuticals Outperform 14
$116.63 Buy/Sell $188.32 59.52%
AUROPHARMA Stock Forecast Aurobindo Pharma Outperform 18
Rp1.06k Buy/Sell Rp1.09k 10.08%

Mallinckrodt Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HIK Stock Forecast Hikma Pharmaceuticals PLC Outperform 18
£19.10 Buy/Sell £28.11 55.34%
ALKS Stock Forecast Alkermes Outperform 10
$28.60 Buy/Sell $33.27 18.88%
RICHTER Stock Forecast Outperform 18
Ft9.66k Buy/Sell Ft11.02k 20.86%

Mallinckrodt EBITDA Forecast for 2023 - 2025 - 2030

Mallinckrodt's EBITDA has seen impressive growth In the last two years, rising from $482.60M to $613.90M – a growth of 27.21%. In the next year, analysts believe that EBITDA will reach $651.16M – an increase of 6.07%. For the next eight years, the forecast is for EBITDA to grow by 6.53%.

2023 EBITDA Forecast
$0.65B
2024 EBITDA Forecast
$0.62B
2025 EBITDA Forecast
$0.67B
2026 EBITDA Forecast
$0.66B
2027 EBITDA Forecast
$0.66B
2028 EBITDA Forecast
$0.64B
2029 EBITDA Forecast
$0.65B
2030 EBITDA Forecast
$0.65B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
APN Stock Forecast Aspen Pharmacare Holdings Outperform 18
R205.91 Buy/Sell R202.49 6.36%
SFZN Stock Forecast Siegfried Holding Outperform 18
CHF921.50 Buy/Sell CHF891.22 8.52%
KRKG Stock Forecast Krka, d. d. Buy 18
123.00€ Buy/Sell 119.80€ 15.85%

Mallinckrodt EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Mallinckrodt's EBIT has decreased by 86.06%, going from $-390.30M to $-54.40M. For the next year, analysts predict that EBIT will reach $-88.02M – an increase of 61.80%. Over the next eight years, experts believe that Mallinckrodt's EBIT will grow at a rate of 76.21%.

2023 EBIT Forecast
$-88017386.67
2024 EBIT Forecast
$-39681171.82
2025 EBIT Forecast
$-92003442.28
2026 EBIT Forecast
$-100207082.55
2027 EBIT Forecast
$-119162922.33
2028 EBIT Forecast
$-87000849.60
2029 EBIT Forecast
$-90733186.04
2030 EBIT Forecast
$-95859611.06
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
JMAT Stock Forecast Johnson Matthey Plc Hold 16
£16.83 Buy/Sell £19.13 5.47%
PRGO Stock Forecast Perrigo Co PLC Outperform 16
$30.59 Buy/Sell $44.75 27.49%
BHC Stock Forecast Bausch Health Companies Hold 15
$9.12 Buy/Sell $9.50 -1.32%

Mallinckrodt EPS Price Prediction Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
IART Stock Forecast Integra LifeSciences Holdings Hold 16
$36.22 Buy/Sell $46.60 20.10%
GLENMARK Stock Forecast Glenmark Pharmaceuticals Outperform 18
Rp955.30 Buy/Sell Rp767.80 -5.32%
AMPH Stock Forecast Amphastar Pharmaceuticals Outperform 14
$43.81 Buy/Sell $69.00 41.52%